Matches in Nanopublications for { ?s ?p "[Frequent promoter hypermethylation of BRCA2, CDH13, MSH6, PAX5, PAX6 and WT1 in ductal carcinoma in situ and invasive breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- assertion description "[Frequent promoter hypermethylation of BRCA2, CDH13, MSH6, PAX5, PAX6 and WT1 in ductal carcinoma in situ and invasive breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Frequent promoter hypermethylation of BRCA2, CDH13, MSH6, PAX5, PAX6 and WT1 in ductal carcinoma in situ and invasive breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP610314.RAu71YsClHskPWcOJ3ZWjRtV1QrlJ8No1T1n_TBSwQE78130_assertion description "[Frequent promoter hypermethylation of BRCA2, CDH13, MSH6, PAX5, PAX6 and WT1 in ductal carcinoma in situ and invasive breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP610314.RAu71YsClHskPWcOJ3ZWjRtV1QrlJ8No1T1n_TBSwQE78130_provenance.
- NP905556.RAljAGLoCQcNovkeBTnP9_kcyxVTGXHVUA5YxFwYUO0z4130_assertion description "[Frequent promoter hypermethylation of BRCA2, CDH13, MSH6, PAX5, PAX6 and WT1 in ductal carcinoma in situ and invasive breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP905556.RAljAGLoCQcNovkeBTnP9_kcyxVTGXHVUA5YxFwYUO0z4130_provenance.
- NP905561.RAjzFrsWlxmRDFoSrhuNCY_M6nXT4d5tKeCiFRqOJg0BE130_assertion description "[Frequent promoter hypermethylation of BRCA2, CDH13, MSH6, PAX5, PAX6 and WT1 in ductal carcinoma in situ and invasive breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP905561.RAjzFrsWlxmRDFoSrhuNCY_M6nXT4d5tKeCiFRqOJg0BE130_provenance.
- NP610549.RA45s35alLOaNz1NvKjBR-H9Cp57T3Zy18Dcj-Gx9mlCs130_assertion description "[Frequent promoter hypermethylation of BRCA2, CDH13, MSH6, PAX5, PAX6 and WT1 in ductal carcinoma in situ and invasive breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP610549.RA45s35alLOaNz1NvKjBR-H9Cp57T3Zy18Dcj-Gx9mlCs130_provenance.